AUTO-GENERATED PAPER DOCUMENT

Company

COSCIENS Biopharma Inc.

Filed

May 24, 2002

Accession Number

9999999997-02-031505

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →